These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3603588)

  • 21. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decrease in the number of rat brain dopamine and muscarinic receptors after chronic alcohol intake.
    Syvälahti EK; Hietala J; Röyttä M; Grönroos J
    Pharmacol Toxicol; 1988 Apr; 62(4):210-2. PubMed ID: 3387375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex vivo 3H-spiroperidol binding to rat striatum and the inhibitory effects of neuroleptics.
    Nakajima T; Egawa E; Kuruma I
    Jpn J Pharmacol; 1981 Apr; 31(2):159-64. PubMed ID: 6118446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]quinuclidinyl benzilate binding in rats.
    Pelham RW; Munsat TL
    Brain Res; 1979 Aug; 171(3):473-80. PubMed ID: 476482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic regulation of muscarinic receptor binding in the corpus striatum.
    Ehlert FJ; Roeske WR; Yamamura HI
    Proc West Pharmacol Soc; 1981; 24():93-5. PubMed ID: 7255494
    [No Abstract]   [Full Text] [Related]  

  • 26. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic dihydroergotoxine treatment affects the number of dopamine recognition sites in rat striatum.
    Battaini F; Govoni S; Rius RA; Spano PF; Trabucchi M
    Pharmacol Res Commun; 1984 Jun; 16(6):605-11. PubMed ID: 6463097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chronic calcium antagonist treatment on dopamine recognition sites in rat striatum.
    Govoni S; Di Giovine S; Moresco RM; Battaini F; Trabucchi M
    Neurosci Lett; 1988 Apr; 87(1-2):173-7. PubMed ID: 3380334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H] Quinuclidinyl benzylate and [3H] GABA receptor binding in rat substantia nigra after 6-hydroxy-dopamine lesions.
    Cross AJ; Waddington JL
    Neurosci Lett; 1980 May; 17(3):271-5. PubMed ID: 6302586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors of the rat striatum.
    Sivam SP; Norris JC; Lim DK; Hoskins B; Ho IK
    J Neurochem; 1983 May; 40(5):1414-22. PubMed ID: 6300336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission.
    Savasta M; Dubois A; Benavidès J; Scatton B
    Neurosci Lett; 1988 Feb; 85(1):119-24. PubMed ID: 2834672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors.
    Kirch DG; Taylor TR; Creese I; Xu SX; Wyatt RJ
    J Pharm Pharmacol; 1992 Feb; 44(2):89-92. PubMed ID: 1352822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
    Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
    J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of chronic administration of haloperidol (intermittently) and haloperidol-decanoate (continuously) on D2 dopamine and muscarinic cholinergic receptors and on carbachol-stimulated phosphoinositide hydrolysis in the rat striatum.
    Akiyama K; Sato M; Yamada N; Otsuki S
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):311-20. PubMed ID: 2830427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACTH/MSH-like peptides inhibit the binding of dopaminergic ligands to the dopamine D2 receptor in vitro.
    Florijn WJ; De Boer T; Tonnaer JA; Van Nispen JW; Versteeg DH
    Eur J Pharmacol; 1991 May; 207(1):43-50. PubMed ID: 1680721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of heavy metal cations, sulfhydryl reagents and other chemical agents on striatal D2 dopamine receptors.
    Scheuhammer AM; Cherian MG
    Biochem Pharmacol; 1985 Oct; 34(19):3405-13. PubMed ID: 3931643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
    Boehme RE; Ciaranello RD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central dopaminergic neurons during development of genetic and DOCA-salt hypertension in the rat.
    Le Fur G; Guilloux F; Kabouche M; Mitrani N; Ferris O; Uzan A
    Brain Res; 1981 Apr; 227(2):153-63. PubMed ID: 7225885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cataleptogenic doses of morphine suppress 3H-spiroperidol binding to striatal membranes.
    Golembiowska-Nikitin K; Pilc A; Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):140-1. PubMed ID: 7202125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.